Literature DB >> 28785465

The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.

Mark A Peterzan1,2, Oliver J Rider2, Lisa J Anderson1.   

Abstract

Cardiovascular imaging is key for the assessment of patients with heart failure. Today, cardiovascular magnetic resonance imaging plays an established role in the assessment of patients with suspected and confirmed heart failure syndromes, in particular identifying aetiology. Its role in informing prognosis and guiding decisions around therapy are evolving. Key strengths include its accuracy; reproducibility; unrestricted field of view; lack of radiation; multiple abilities to characterise myocardial tissue, thrombus and scar; as well as unparalleled assessment of left and right ventricular volumes. T2* has an established role in the assessment and follow-up of iron overload cardiomyopathy and a role for T1 in specific therapies for cardiac amyloid and Anderson-Fabry disease is emerging.

Entities:  

Keywords:  Cardiovascular magnetic resonance; T1 mapping; T2*; cardio-oncology; cardiomyopathy; delayed enhancement; heart failure; late gadolinium enhancement; myocarditis; prognosis

Year:  2016        PMID： 28785465      PMCID： PMC5490982          DOI： 10.15420/cfr.2016.2.2.115

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


  170 in total

1.  MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial.

Authors:  Juerg Schwitter; Christian M Wacker; Norbert Wilke; Nidal Al-Saadi; Ekkehart Sauer; Kalman Huettle; Stefan O Schönberg; Andreas Luchner; Oliver Strohm; Hakan Ahlstrom; Thorsten Dill; Nadja Hoebel; Tamas Simor
Journal:  Eur Heart J       Date:  2012-03-04       Impact factor: 29.983

2.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

3.  Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Authors:  Daniela Cardinale; Alessandro Colombo; Maria T Sandri; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Giovanni Martinelli; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

4.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

5.  Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.

Authors:  Theodorus A M Kaandorp; Jeroen J Bax; Joanne D Schuijf; Eric P Viergever; Ernst E van Der Wall; Albert de Roos; Hildo J Lamb
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

6.  Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction.

Authors:  Jonathan W Weinsaft; Han W Kim; Dipan J Shah; Igor Klem; Anna Lisa Crowley; Rhoda Brosnan; Olga G James; Manesh R Patel; John Heitner; Michele Parker; Eric J Velazquez; Charles Steenbergen; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

7.  Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.

Authors:  Frank Weidemann; Markus Niemann; Frank Breunig; Sebastian Herrmann; Meinrad Beer; Stefan Störk; Wolfram Voelker; Georg Ertl; Christoph Wanner; Jörg Strotmann
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

8.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983

9.  Myocardial feature tracking reduces observer-dependence in low-dose dobutamine stress cardiovascular magnetic resonance.

Authors:  Andreas Schuster; Matthias Paul; Nuno Bettencourt; Shazia T Hussain; Geraint Morton; Shelby Kutty; Boris Bigalke; Amedeo Chiribiri; Divaka Perera; Eike Nagel; Philipp Beerbaum
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

10.  Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Nizar A Ismail; Kishen Morarji; Aamir Ali; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Emmanouil Liodakis; Arun J Baksi; Rameen Shakur; Kaushik Guha; Michael Roughton; Ricardo Wage; Stuart A Cook; Francisco Alpendurada; Ravi G Assomull; Raad H Mohiaddin; Martin R Cowie; Dudley J Pennell; Sanjay K Prasad
Journal:  Eur J Heart Fail       Date:  2013-03-08       Impact factor: 15.534
View more
  8 in total

Review 1.  Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.

Authors:  Tomoko S Kato; Masao Daimon; Toru Satoh
Journal:  Curr Cardiol Rep       Date:  2019-05-10       Impact factor: 2.931

2.  Residual Learning: A New Paradigm to Improve Deep Learning-Based Segmentation of the Left Ventricle in Magnetic Resonance Imaging Cardiac Images.

Authors:  Maral Zarvani; Sara Saberi; Reza Azmi; Seyed Vahab Shojaedini
Journal:  J Med Signals Sens       Date:  2021-07-21

Review 3.  Cardiovascular Magnetic Resonance Imaging: A Prospective Modality in the Diagnosis and Prognostication of Heart Failure.

Authors:  Jalal Elmadi; Lakshmi Satish Kumar; Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy; Zineb Barkhane
Journal:  Cureus       Date:  2022-04-05

4.  The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.

Authors:  Robert D Adam; James Shambrook; Andrew S Flett
Journal:  Card Fail Rev       Date:  2017-11

5.  Guideline for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 1: Standardized Protocol.

Authors:  Yeseul Jo; JeongJae Kim; Chul Hwan Park; Jae Wook Lee; Jee Hye Hur; Dong Hyun Yang; Bae Young Lee; Dong Jin Im; Su Jin Hong; Eun Young Kim; Eun Ah Park; Pan Ki Kim; Hwan Seok Yong
Journal:  Korean J Radiol       Date:  2019-09       Impact factor: 3.500

6.  The three-dimensional speckle tracking echocardiography in distinguishing between ischaemic and non-ischaemic aetiology of heart failure.

Authors:  Marianna Vachalcova; Gabriel Valočik; Marián Kurečko; Julia Grapsa; Viktória Ali Taha; Peter Michalek; Monika Jankajová; František Sabol; Lucia Kubikova; Marek Orban; Tomas Uher; Allan Böhm
Journal:  ESC Heart Fail       Date:  2020-06-19

7.  A Late Diagnosis of Transthyretin Amyloidosis.

Authors:  Kristopher S Pfirman; William Newton; Collins Garst; Sharvil Patel; Jacqueline Dawson Dowe
Journal:  Cureus       Date:  2022-01-21

8.  30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper.

Authors:  Subha V Raman; Michael Markl; Amit R Patel; Jennifer Bryant; Bradley D Allen; Sven Plein; Nicole Seiberlich
Journal:  J Cardiovasc Magn Reson       Date:  2022-03-01       Impact factor: 5.364
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.